Topical Minoxidil Improves Hair Growth in 87% of Pediatric Patients With Chemotherapy-Induced Alopecia
Pharmacy Times
MARCH 18, 2024
The FDA-approved topical and oral agent is currently indicated for adult patients with patterned alopecia.
topic patient 
Aiming for Improved Efficacy and Patient Compliance for Topical Ophthalmics
PharmaTech
FEBRUARY 2, 2023
Topical eye treatments can be beneficial for patients with a growing array of eye diseases, but only if taken appropriately.
52 Join 33,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Three years after an FDA rejection, DBV sees a path for its peanut patch
PharmaVoice
SEPTEMBER 22, 2023
Despite lower-than-expected demand for a competing treatment, DBV’s chief medical officer says the company’s topical skin patch could be a game-changing option for patients.
307 
From trial design for patients to trial design with patients: a key topic at DIA ’22
pharmaphorum
JUNE 30, 2022
At the 2022 Drug Information Association (DIA) annual meeting last week, it was inspiring to connect with fellow research and development (R&D) stakeholders, regulators, health and digital data partners and more to navigate challenges in drug development that impact patients globally. Patient journey. Patient access.
Counsel Patients On Topical Niacinamide for Acne Treatment and Beyond
Pharmacy Times
FEBRUARY 29, 2024
Topical niacinamide stabilizes the skin's outer barrier, reducing water loss and improving moisture levels in the epidermis.
49 
STAT+: Clinical notes automation startup Abridge raises $150 million, takes aim at Microsoft Nuance
STAT
FEBRUARY 22, 2024
Abridge sells an AI tool that rapidly transcribes and summarizes doctors’ conversations with patients in a hospital’s electronic health records software. The startup, Abridge, also has an unlikely cheerleader: Paul Ricci, the former head of Nuance, the service from Microsoft it competes with.
Hospitals 310
310 Hospitals 310
310 
STAT+: House committee hearing kicks off potential doctor pay reforms in Medicare
STAT
OCTOBER 19, 2023
Lawmakers brought up 23 different bills on the topic, many of which are drafts that haven’t been introduced. If Congress does not act before the end of the year, Medicare will cut payments to doctors in certain rural areas and laboratories that run tests used in caring for patients.
286 
FDA Approves Birch Triterpenes Topical Gel for Treatment for Adult, Pediatric Patients With JEB, DEB
Pharmacy Times
DECEMBER 19, 2023
This approval makes birch triterpenes the first treatment for wounds associated with junctional epidermolysis bullosa to be approved by the FDA.
55 
Opinion: Checklists to screen for patients’ social needs aren’t helping
STAT
MAY 22, 2023
I once saw a patient who came to the emergency room with injuries that were clearly related to domestic violence. While facing the computer screen, the nurse asked the patient a series of sensitive questions, including one about whether she had experienced domestic violence. Read the rest…
264 
STAT+: FDA approves first treatment for skin condition that causes persistent wounds, a redosable gene therapy
STAT
MAY 19, 2023
The therapy, known as Vyjuvek and made by Krystal Biotech, will soon be available for patients with dystrophic epidermolysis bullosa, a genetic disease that causes painful blisters and persistent wounds. Patients with the condition live covered in bandages to try to stop new blisters from forming and to dress their wounds.
259 
STAT+: In surprise move, FDA calls for advisory committee on Lilly’s Alzheimer’s drug
STAT
MARCH 8, 2024
A date for the meeting has not been set yet.
326 
SAEM Clinical Images Series: Pediatric Genitourinary Bleeding
ALiEM - Pharm Pearls
NOVEMBER 17, 2023
The grandmother first noted blood in the patient’s underwear the previous morning when she was helping the patient wipe and she noticed it again prior to arrival, this time saturating the patient’s underwear. Of note, the patient’s father took her to a trampoline park with her younger sister two days ago.
249 
Opinion: What the recent failures of Mindstrong and Pear tell us about the future of digital mental health
STAT
APRIL 18, 2023
Over the past five years, digital mental health has risen from a niche topic to a global health priority. Patients, researchers, regulators, and investors alike are thrilled by the potential of ubiquitous mobile technology like smartphones to help diagnose problems, monitor health, and even deliver evidence-based therapies.
248 
11 Tips to Improve Epistaxis Management in the Emergency Department
ALiEM - Pharm Pearls
MARCH 3, 2023
This is a less true in pediatric patients. The following 11 pearls with a bonus tip should help you avoid common pitfalls, improve outcomes, and increase both patient and physician satisfaction: Wear proper protection during the procedure, including a face shield and gown. Prepare your equipment in advance.
Documentation 301
301 Documentation 301
301 
Sun Pharma gets approval for Winlevi in Australia
Express Pharma
MARCH 18, 2024
Winlevi is indicated for the topical treatment of acne vulgaris in patients 12 years of age and older. Diana Harbort, President of the Dermatology Division of Cosmo, said, “We are very pleased that Winlevi will soon be available to patients in Australia. Winlevi will be available in Australia this June.
93 
Sri Harsha V, AVP – BD and Sales, Sigachi Industries
Express Pharma
APRIL 16, 2024
In this video: Sri Harsha V, AVP – BD and Sales, Sigachi Industries Topic: Technology leadership and brand repositioning Key Takeaway: Achieving technology leadership involves age-appropriate drug delivery, for e.g. geriatric patients.
52 
ASBM and GaBI Webinar Examines Policy Challenges to Interchangeable Biosimilars
Safe Biologics
DECEMBER 8, 2023
On November 30, ASBM and the Generics and Biosimilars Initiative (GaBI) hosted I nterchangeable Designation for Biosimilars- Ensuring Continuity of Patient Care: Upholding Interchangeability Status for Biosimilars. The webinar was the fourth in a series covering key health policy issues.
Biosimilars 130
130 
How I Educate Series: Jacob Avila, MD
ALiEM - Pharm Pearls
APRIL 5, 2023
There are always things to learn and there are patients attached to the diseases. The amount that I teach definitely depends on patient volume. I live to teach, but I don’t sacrifice patient care in the moment to orate. Do you typically see patients before or after they are presented to you? EVERYTHING.
Documentation 130
130 
Glaucoma
RX Note
APRIL 3, 2024
Initially, this condition tends to be asymptomatic, however, as glaucoma progresses, patients may present with irreversible sight loss or visual field defects. Initial treatment of glaucoma is generally with topical drugs; selective laser trabeculoplasty may be considered in some patients.
Dosage 52
52 
Sun Pharma Canada launches WINLEVI for acne
Express Pharma
SEPTEMBER 27, 2023
WINLEVI is the first and only androgen receptor inhibitor indicated for the topical treatment of acne vulgaris (acne) in patients 12 years of age and older. Sun Pharma Canada has launched WINLEVI (clascoterone cream 1% w/w) in Canada. WINLEVI is thought to reduce the effects of acne hormones on skin by disrupting the androgen cascade.
97 
GaBI Journal Publishes ASBM Whitepaper on Medicare Part D Price Setting
Safe Biologics
FEBRUARY 1, 2024
In January, the Generics and Biosimilars Initiative (GaBI) published a whitepaper entitled “ Medicare Drug Price Negotiations: Impact on Healthcare Development and Patient Access to Medicines” The paper’s content is drawn from a webinar on the same topic hosted by ASBM and GaBI on July 26, 2023.
Drug Pricing 100
100 
Vinay Chaturvedi, VP-Operations, Zuventus Healthcare
Express Pharma
APRIL 2, 2024
In this video: Vinay Chaturvedi, VP-Operations, Zuventus Healthcare Topic: Innovations in drug discovery and development Key Takeaway: AI, data analytics, patient-centric trials, assay development, advanced manufacturing, synthetic biology, high performance computing, 3D cell culture etc are some of the exciting advancements in drug discovery and development (..)
52 
It’s been a long time coming for long-term topical psoriasis treatments
pharmaphorum
OCTOBER 26, 2022
Topicals — creams, ointments, foams, and lotions applied directly to the affected areas of the skin — don’t get nearly as much TV time as their systemic biologic counterparts, the self-injectables with catchy theme songs, where the smiley and sleeveless walk confidently down the street and/or swim. How to quantify severity.
Immunity 98
98 
Five Ways Preceptors May Integrate Generative Artificial Intelligence Programs Into Pharmacy Education Learning Experiences
ID Stewardship
DECEMBER 12, 2023
Article posted 13 December 2023 Artificial intelligence is a hot topic today. At all of the major conferences lately there seem to be well-attended lectures on the topic and often it will be even mentioned if not the in the keynote speech. In terms of pharmacy education research on the topic of AI, there is not a lot out there.
Communication 109
109 Communication 109
109 
Post-event glimpse into the Pharma Industry Townhall
Express Pharma
MARCH 20, 2024
The event garnered widespread acclaim for its focus on updating professionals on new-age skill sets and gaining in-depth knowledge of trending topics to address today’s day and age challenges in the sales and marketing realm of the Pharma Industry. The trending topics were discussed in four talks & presentation formats.
Investing in the gleams of positivity and hope for life sciences innovation
pharmaphorum
DECEMBER 28, 2023
In this third instalment of the five-part, festive series of the pharmaphorum podcast, web editor Nicole Raleigh speaks with Mark Andrews, investment director of life sciences funds at British Patient Capital (BPC), discussing the vitally hot topic of investment in life sciences.
62 
Atopic Dermatitis (Eczema)
RX Note
JULY 15, 2023
Standard treatment modalities for the management of these patients are centred around the use of topical antiinflammatory preparations and moisturization of the skin, but patients with severe disease may require phototherapy or systemic treatment. pimecrolimus and tacrolimus) is effective in controlling pruritus.
52 
US FDA grants approval to Incyte’s Opzelura cream for vitiligo treatment
Pharmaceutical Technology
JULY 19, 2022
as a topical treatment of nonsegmental vitiligo in adults and paediatric patients aged 12 years and above. Opzelura is a topical formulation of a Janus kinase (JAK) inhibitor. With the latest development, Opzelura has became the first treatment for repigmentation in patients with vitiligo to receive FDA approval.
Labelling 116
116 Labelling 116
116 
Cosmo, Glenmark signs distribution and license pacts for Winlevi in Europe, South Africa
Express Pharma
SEPTEMBER 27, 2023
Winlevi has been approved by the United States Food & Drug Administration (US FDA) as a novel drug with a unique mechanism of action for the topical treatment of acne in patients aged 12 years and older. Winlevi has become the most prescribed branded topical acne drug in the US.; million in 2021 to $1,297.0 million in 2028.
94 
Topical Corticosteroids
RX Note
JULY 15, 2023
Introduction Topical corticosteroids have a major role in the management of many skin diseases. Potency The selection often depends, to some extent, upon the severity, site and the patient's age. # If you read United States reference (such as Lexicomp ), topical corticosteroids can be classified into 7 groups according to potency.
Diabetes 52
52 Diabetes 52
52 
GaBI Journal publishes Meeting Report on ASBM Non-Medical Switching Webinar
Safe Biologics
MAY 5, 2023
During the webinar, academic clinicians, patient advocates, policymakers and regulatory experts from Canada and the US shared their experience and knowledge.
Biosimilars 100
100 Biosimilars 100
100 
GaBI Journal publishes Meeting Report on ASBM Non-Medical Switching Webinar
Safe Biologics
MAY 5, 2023
During the webinar, academic clinicians, patient advocates, policymakers and regulatory experts from Canada and the US shared their experience and knowledge.
Biosimilars 100
100 Biosimilars 100
100 
FDA Approves Expanded Indication for LEO Pharma's Adbry for Pediatric Patients With Atopic Dermatitis
PharmExec
DECEMBER 19, 2023
Indication of Adbry (tralokinumab-ldrm) expanded to include patients 12 to 17 years of age with moderate-to-severe atopic dermatitis whose disease is not adequately controlled with topical prescription therapies or for whom those therapies are not advisable.
52 
US FDA updates Sanofi’s Dupixent label for atopic dermatitis
Pharmaceutical Business Review
JANUARY 17, 2024
This label update is based on findings from the Phase III LIBERTY-AD-HAFT trial, the first to evaluate a biologic for this patient group. The LIBERTY-AD-HAFT trial involved 133 adult and adolescent patients with atopic dermatitis who had not responded adequately to topical corticosteroids. It is not an immunosuppressant.
Labelling 103
103 Labelling 103
103 
Krystal Biotech receives FDA approval for DEB topical gene therapy
Pharmaceutical Technology
MAY 26, 2023
Krystal Biotech has received approval from the US Food and Drug Administration for topical gene therapy VYJUVEK to treat dystrophic epidermolysis bullosa (DEB) in adults and in children aged six months and above. Patients with DEB have extremely fragile skin that blisters and tears with minor trauma or friction such as scratching or rubbing.
105 
Trick of the Trade: Gel-free ultrasound-guided peripheral IV technique
ALiEM - Pharm Pearls
APRIL 12, 2023
You set up everything, have the patient positioned, and then notice there is no sterile ultrasound gel. The trick is to eliminate anything of poor acoustic impedance between the ultrasound probe and the patient’s skin. Ever finally step away from a busy resuscitation and someone stops you for peripheral IV access? No problem.
257 
Trick of the Trade: Antibiotic ointment for removal of artificial nail glue from eyelids
ALiEM - Pharm Pearls
FEBRUARY 8, 2023
A bottle of nail glue and timolol eye drops (reproduced with permission from BMJ Publishing Group Ltd [1]) You are working a busy shift in your department’s fast track area and sign up for a patient with a complaint of “eye pain.” The patient is a fan of glue-on nails and mistook her nail glue bottle for her eyedrops.
Packaging 130
130 Packaging 130
130 
Breaking Down the 2024 PRITE Blueprint
Board Vitals - Pharmacist
NOVEMBER 15, 2023
The PRITE covers a broad range of topics within the field of psychiatry. Administered annually, it covers a wide array of topics to ensure a well-rounded evaluation of a resident’s understanding of psychiatry. What is the PRITE ? What is the PRITE ? Let’s break down the latest PRITE blueprint : A.
98 
Should older adults take vitamin D to protect their heart?
The Pharmacist
JULY 12, 2023
Do the findings of a recent randomised trial now offer patients a clearer picture? Rod Tucker takes a closer look, in the next topic examined in our Review series. Observational and randomised trial findings provide conflicting evidence over whether supplementing with vitamin D may benefit heart health in older adults.
79 
Onychomycosis
RX Note
JULY 15, 2023
The infection is common but probably underreported because of patient embarrassment or ignorance that they have an infection. Management No treatment other than nail trimming may be appropriate for asymptomatic patients who are not bothered by the infected nail or who wish to avoid the possible effects of drug treatment.
EC approves lebrikizumab for atopic dermatitis
European Pharmaceutical Review
NOVEMBER 17, 2023
The European Commission has approved Ebglyss (lebrikizumab) for atopic dermatitis patients 12 years and older with a body weight of at least 40kg, who are candidates for systemic therapy. The Phase III clinical development programme, which involved some 1,300 patients, also evaluated the safety profile of lebrikizumab.
Hospitals 85
85 Hospitals 85
85 
How Patient Centricity is a Business Imperative for Life Sciences Companies
PharmExec
AUGUST 1, 2023
Patient centricity is an imperative focus for the advancement of life sciences businesses, and Sharon Suchotliff from ZS delves into this topic by sharing her keen insights.
52 
Soligenix and Silk Road sign deal for Behçet’s disease treatment rights
Pharmaceutical Technology
MAY 2, 2023
Soligenix has signed an exclusive option agreement with Silk Road Therapeutics for the right to acquire Pentoxifylline (PTX) topical formulation intended to treat mucocutaneous ulcers in Behçet’s disease (BD) patients. Patients applied the PTX mucoadhesive gel four times a day for up to 14 days for treating current mouth ulcers.
52 
Dermatitis
RX Note
JULY 15, 2023
Topical corticosteroids Patient should be instructed to use a fingertip unit. Topical corticosteroids should be applied liberally, not sparingly, to areas of inflamed skin until the skin is completely clear. Patients and parents should be reassured that the benefits outweigh the harms and they should not be afraid to use them.
Let's personalize your content